Understanding the effect of increased cell specific productivity on galactosylation of monoclonal antibodies produced using Chinese hamster ovary cells

2021 ◽  
Vol 329 ◽  
pp. 92-103
Author(s):  
Sri R. Madabhushi ◽  
Alexei A. Podtelezhnikov ◽  
Nicholas Murgolo ◽  
Sen Xu ◽  
Henry Lin
Author(s):  
Shazid Md. Sharker ◽  
Md. Atiqur Rahman

Most of clinical approved protein-based drugs or under in clinical trial have a profound impact in the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the biopharmaceutical industry for the mass-production of therapeutic protein. Recent advances in CHO cell bioprocessing to yield recombinant proteins and monoclonal antibodies have enabled the expression of quality protein. The developments of cell lines are possible to upgrade specific productivity. As a result, it holds an interesting area for academic as well as industrial researchers around the world. This review will concentrate on the recent progress of the mammalian CHO cells culture technology and the future scope of further development for the mass-production of protein therapeutics.


2013 ◽  
Vol 30 (1) ◽  
pp. 188-197 ◽  
Author(s):  
Leon P. Pybus ◽  
David C. James ◽  
Greg Dean ◽  
Tim Slidel ◽  
Colin Hardman ◽  
...  

mAbs ◽  
2015 ◽  
Vol 7 (2) ◽  
pp. 413-427 ◽  
Author(s):  
Thomas McNerney ◽  
Anne Thomas ◽  
Anna Senczuk ◽  
Krista Petty ◽  
Xiaoyang Zhao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document